Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine in mild and moderate COVID-19
NCT04891302Phase 2Completed
- Sponsor
- Bukwang Pharmaceutical
- Start
- Mar 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clevudine in coronavirus disease 2019 (COVID-19), sponsored by Bukwang Pharmaceutical. Started Mar 2021; status: completed.
02
Drugs
clevudine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04891302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04891302.